Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, R&D

President and CEO

Chief Accounting Officer

Chief Commercial Officer

Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the United States. It develops beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa; KB105 for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for netherton syndrome; and KB407 for Cystic Fibrosis. The company also develops KB408 for Alpha-1 antitrypsin deficiency; and KB301 for aesthetic skin conditions. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Krystal Biotech, Inc., a biotechnology company, develops and commercializes genetic medicines for patients with rare diseases in the Unite...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-11	Premium	sold	Premium	Premium	Premium	President, R&D
2024-03-11	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-11	Premium	sold	Premium	Premium	Premium	President and CEO
2024-03-11	Premium	sold	Premium	Premium	Premium	President, R&D
2024-02-28	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-02-28	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	President, R&D
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2024-02-28	Premium	acquired	Premium	Premium	Premium	President, R&D
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2024-02-28	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2024-02-28	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-02-28	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-28	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-02-27	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	President, R&D
2024-02-26	Premium	sold (taxes)	Premium	Premium	Premium	Chief Accounting Officer
2024-02-26	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2024-02-26	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-01-22	Premium	sold	Premium	Premium	Premium	Chief Accounting Officer
2024-01-22	Premium	acquired	Premium	Premium	Premium	Chief Accounting Officer
2023-12-11	Premium	sold	Premium	Premium	Premium	President, R&D

KRYS - Krystal Biotech Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for KRYS